Back
Oracle Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
71
ORCL
Oracle
Last Price:
189.54
Seasonality Move:
11.84%
Sell
46
ANIP
ANI Pharmaceuticals
Last Price:
61.01
Seasonality Move:
5.08%
Buy
71
Oracle (ORCL)
is a Buy
Is Oracle a Buy, Sell or Hold?
- The current Oracle [ORCL] share price is $189.13. The Score for ORCL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- ORCL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.85. The Score for ANIP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ORCL Stock Price Chart
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.58 | Buy |
| Relative Strength Index (14 RSI): | 72.87 | Buy |
| Chaikin Money Flow: | -1754641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (170.15 - 180.99) | Buy |
| Bollinger Bands (100): | (136.06 - 170.24) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 60.98 | Buy |
| Chaikin Money Flow: | 213168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.99) | Buy |
| Bollinger Bands (100): | (57.71 - 62.95) | Buy |
ORCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 178.15 | Buy |
| 20-day SMA: | 175.77 | Buy |
| 50-day SMA: | 167.75 | Buy |
| 200-day SMA: | 136.6 | Buy |
| 8-day EMA: | 181.5 | Buy |
| 20-day EMA: | 176.49 | Buy |
| 50-day EMA: | 167.59 | Buy |
| 200-day EMA: | 142.08 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.64 | Buy |
| 20-day SMA: | 58.88 | Buy |
| 50-day SMA: | 58.7 | Buy |
| 200-day SMA: | 62.08 | Sell |
| 8-day EMA: | 59.48 | Buy |
| 20-day EMA: | 58.83 | Buy |
| 50-day EMA: | 59.09 | Buy |
| 200-day EMA: | 59.9 | Buy |
Oracle Earnings Growth & ORCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.70 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Oracle Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||